Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05976490 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NeuroPathways Intervention for Brain Tumor Patients

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Sep 10, 2026 → Oct 5, 2027
See other at-risk trials from Massachusetts General Hospital

Record History

  1. Primary completion pushed from Sep 10, 2026 to Oct 5, 2027 Completion pushed from Apr 10, 2027 to Oct 5, 2027 · Eligibility criteria expanded, about 6 words Show 2 more changesShow less
    • Completion pushed from Apr 10, 2027 to Oct 5, 2027
    • Eligibility criteria expanded, about 6 words
  2. Primary completion date: Sep 10, 2025 to Sep 10, 2026 Completion date: Apr 10, 2026 to Apr 10, 2027 · Start date: Oct 16, 2023 to Nov 7, 2023v4 Show 2 more changesShow less
    • Completion date: Apr 10, 2026 to Apr 10, 2027
    • Start date: Oct 16, 2023 to Nov 7, 2023
  3. Re-verified, no change to tracked fieldsv3
  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Sep 10, 2023 to Oct 16, 2023 · Site details revisedv2 Show 2 more changesShow less
    • Start date changed from estimate of Sep 10, 2023 to Oct 16, 2023
    • Site details revised
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This goal of this study is to test an information and support intervention for patients with malignant (or "high-grade") brain tumors. This study was developed to help patients cope after a brain tumor diagnosis. The main question this study aims to answer is whether this intervention (which includes access to an information guide and one-on-one coaching sessions) is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in the coaching sessions, use the guide as desired, and complete a small group of short surveys at three different points in time; some participants will be asked to share feedback via exit interviews.
Trial Details
NCT Number NCT05976490
Lead Sponsor Massachusetts General Hospital
Conditions Malignant Brain Tumor, Glioma, Coping Skills
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov